Regulation of age-associated insulin resistance by MT1-MMP-mediated cleavage of insulin receptor

Nat Commun. 2022 Jun 29;13(1):3749. doi: 10.1038/s41467-022-31563-2.

Abstract

Insulin sensitivity progressively declines with age. Currently, the mechanism underlying age-associated insulin resistance remains unknown. Here, we identify membrane-bound matrix metalloproteinase 14 (MT1-MMP/MMP14) as a central regulator of insulin sensitivity during ageing. Ageing promotes MMP14 activation in insulin-sensitive tissues, which cleaves Insulin Receptor to suppress insulin signaling. MT1-MMP inhibition restores Insulin Receptor expression, improving insulin sensitivity in aged mice. The cleavage of Insulin Receptor by MT1-MMP also contributes to obesity-induced insulin resistance and inhibition of MT1-MMP activities normalizes metabolic dysfunctions in diabetic mouse models. Conversely, overexpression of MT1-MMP in the liver reduces the level of Insulin Receptor, impairing hepatic insulin sensitivity in young mice. The soluble Insulin Receptor and circulating MT1-MMP are positively correlated in plasma from aged human subjects and non-human primates. Our findings provide mechanistic insights into regulation of insulin sensitivity during physiological ageing and highlight MT1-MMP as a promising target for therapeutic avenue against diabetes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age Factors
  • Animals
  • Humans
  • Insulin / metabolism
  • Insulin Resistance*
  • Matrix Metalloproteinase 14* / metabolism
  • Mice
  • Receptor, Insulin* / metabolism
  • Signal Transduction

Substances

  • Insulin
  • Receptor, Insulin
  • MMP14 protein, human
  • Matrix Metalloproteinase 14